Catalyst Wire Dossier Catalyst Wire Dossier

CASAD (Calcium Aluminosilicate Anti-Diarrheal)

Calcium aluminosilicate anti-diarrheal · Salient Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CASAD (Calcium Aluminosilicate Anti-Diarrheal), covering 2013-03-08 to 2013-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection [Phase 2]

See pricing